GlaxoSmithKline has won approval for the first of vaccine against human papilloma virus,or HPV, to be licensed for use in China.
RIGHT BG
GlaxoSmithKline has won approval for the first of vaccine against human papilloma virus,or HPV, to be licensed for use in China.
GSK's HPV vaccine approved in China
2016-07-19First HPV vaccine gets greenlight to enter Chinese mainland market
2016-07-19Women flock to Hong Kong for HPV inoculations
2016-05-23